Your browser doesn't support javascript.
loading
Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
Halahleh, Khalid; Al Sawajneh, Suhaib; Saleh, Yacob; Shahin, Omar; Abufara, Alaa; Ma'koseh, Mohamad; Abdel-Razeq, Rashid; Barakat, Fareed; Abdelkhaleq, Hadeel; Al-Hassan, Nadira; Atiyyat, Reem; Al-Faker, Noor; Omari, Zaid; Ghatasheh, Hamza; Jaradat, Imad; Muradi, Isa; Iyad, Sultan; Bazarbachi, Ali.
Affiliation
  • Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. Electronic address: Kh.06314@khcc.jo.
  • Al Sawajneh S; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Saleh Y; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Shahin O; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Abufara A; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Ma'koseh M; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Abdel-Razeq R; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Barakat F; Department of Hematopathology, King Hussein Cancer Center, Amman, Jordan.
  • Abdelkhaleq H; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan.
  • Al-Hassan N; Department of Nursing, King Hussein Cancer Center, Amman, Jordan.
  • Atiyyat R; Department of Nursing, King Hussein Cancer Center, Amman, Jordan.
  • Al-Faker N; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
  • Omari Z; Department of Radiology, King Hussein Cancer Center, Amman, Jordan.
  • Ghatasheh H; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan.
  • Jaradat I; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan.
  • Muradi I; Department of Medicine, University of Tripoli, Tripoli, Libya.
  • Iyad S; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan.
  • Bazarbachi A; Bone Marrow Transplantation Department, American University of Beirut, Beirut, Lebanon.
Clin Lymphoma Myeloma Leuk ; 22(8): 589-595, 2022 08.
Article in En | MEDLINE | ID: mdl-35490153
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2022 Document type: Article